BeyondSpring, Inc. (BYSI)
0.5847
+0.01
(+1.02%)
USD |
NASDAQ |
Nov 17, 16:00
0.5847
0.00 (0.00%)
After-Hours: 20:00
BeyondSpring EPS Diluted (Quarterly) : -0.0701 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0701 |
| June 30, 2026 | -0.0206 |
| March 31, 2026 | -0.0525 |
| December 31, 2025 | -0.0526 |
| September 30, 2025 | -0.0382 |
| June 30, 2025 | -0.0448 |
| March 31, 2025 | -0.0622 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.2444 |
| September 30, 2021 | -0.4707 |
| June 30, 2021 | -0.4949 |
| March 31, 2021 | -0.4355 |
| December 31, 2020 | -0.5199 |
| September 30, 2020 | -0.4798 |
| June 30, 2020 | -0.4567 |
| March 31, 2020 | -0.58 |
| December 31, 2019 | -0.5194 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.3701 |
| June 30, 2019 | -0.3184 |
| March 31, 2019 | -0.3167 |
| December 31, 2018 | -0.6134 |
| September 30, 2018 | -0.6505 |
| June 30, 2018 | -0.54 |
| March 31, 2018 | -0.61 |
| December 31, 2017 | -0.68 |
| September 30, 2017 | -0.68 |
| June 30, 2017 | -0.584 |
| March 31, 2017 | -2.66 |
| December 31, 2016 | -0.16 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.21 |
| March 31, 2016 | -0.12 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Arrowhead Pharmaceuticals, Inc. | -3.029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.064M |
| Total Expenses (Quarterly) | 2.064M |
| Enterprise Value | 23.47M |
| Earnings Yield | -33.49% |
| Normalized Earnings Yield | -33.49 |